| 1 | MANBA
|
| Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
|
| Damme M, Stroobants S, Walkley SU, Lüllmann-Rauch R, D'Hooge R, Fogh J, Saftig P, Lübke T, Blanz J.
|
| J Neuropathol Exp Neurol 70(1):83-94.
2011
|
| 2 | MANBA
|
| A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.
|
| Sabourdy F, Labauge P, Stensland HM, Nieto M, Garcés VL, Renard D, Castelnovo G, de Champfleur N, Levade T.
|
| BMC Med Genet 10:84.
2009
|
| 3 | MANBA
|
| Cloning, sequence, expression and characterization of human beta-mannosidase.
|
| Samra ZQ, Athar MA.
|
| Acta Biochim Pol 55(3):479-90. Epub 2008 Sep 17.
2008
|
| 4 | MANBA
|
| Human beta-mannosidase cDNA characterization and first identification of a mutation associated with human beta-mannosidosis.
|
| Alkhayat AH, Kraemer SA, Leipprandt JR, Macek M, Kleijer WJ, Friderici KH.
|
| Hum Mol Genet 7(1):75-83. 1998
|
| 5 | MANBA
|
| Molecular cloning and characterization of bovine beta-mannosidase.
|
| Chen H, et al.
|
| J Biol Chem 270 : 3841-3848. 1995
|